Clinitech Laboratory Share Price
30.00+0.00 (+0.00%)
-28.57% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
APOLLOHOSP-ANSE
MAXHEALTH-ANSE
ASTERDM-ANSE
FORTIS-ANSE
NH-ANSE
MEDANTA-ANSE
LALPATHLAB-ANSE
KIMS-ANSE
AGARWALEYE-ANSE
VIJAYA-ANSE
CTLLAB-MNSE
Clinitech Laboratory Share Price
30.00+0.00 (+0.00%)
-28.57% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 15% |
| - | - | - | 5% |
| - | - | - | -29% |
| 5% | 5% | 5% | 5% |
Peer Comparison
Symbol
APOLLOHOSP-A
MAXHEALTH-A
ASTERDM-A
FORTIS-A
NH-A
MEDANTA-A
LALPATHLAB-A
KIMS-A
AGARWALEYE-A
VIJAYA-A
CTLLAB-M
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 8,510.05 | ₹121412 Cr | 58.11 | 40.39 | 207.67 | ₹1942 Cr |
| 919.3 | ₹87015 Cr | 63.03 | 4.26 | 19.36 | ₹1442 Cr |
| 690.7 | ₹59431 Cr | 186.49 | 0.31 | 6.76 | ₹388 Cr |
| 788.6 | ₹59227 Cr | 56.52 | 3.53 | 20.1 | ₹1042 Cr |
| 1,901.65 | ₹38205 Cr | 44.49 | 14.73 | 71.14 | ₹806 Cr |
| 1,386.25 | ₹35671 Cr | 57.68 | 8.21 | 32.95 | ₹556 Cr |
| 1,933.1 | ₹32373 Cr | 59.74 | 10.11 | 42.51 | ₹505 Cr |
| 736.15 | ₹30682 Cr | 150.18 | 1.04 | 12.74 | ₹241 Cr |
| 522.4 | ₹16250 Cr | 109.52 | 1.43 | 13.88 | ₹133 Cr |
| 1,423.45 | ₹14914 Cr | 79.54 | 5.16 | 27.53 | ₹173 Cr |
| 30 | ₹7 Cr | 16.38 | 0.53 | 4.07 | ₹42 L |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 |
|---|---|
| — | — |
| ₹2 Cr | ₹2 Cr |
| ₹7 Cr | ₹7 Cr |
| ₹7 Cr | ₹7 Cr |
| ₹9 Cr | ₹9 Cr |
| ₹49,000 | ₹0 |
| ₹54 L | ₹0 |
| -₹20 L | -₹17 L |
| ₹25 L | ₹20 L |
| ₹59 L | ₹3 L |
| — | — |
| ₹48 L | ₹76 L |
| ₹43 L | ₹74 L |
| ₹22 L | ₹31 L |
| ₹1 Cr | ₹2 Cr |
| ₹11 Cr | ₹11 Cr |
| ₹54 L | ₹0 |
| — | — |
| ₹6 Cr | ₹5 Cr |
| ₹4 Cr | ₹3 Cr |
| ₹2 Cr | ₹2 Cr |
| ₹26 L | ₹0 |
| ₹7 L | ₹7 L |
| ₹7 L | ₹7 L |
| ₹9 L | ₹0 |
| ₹4 Cr | ₹3 Cr |
| — | — |
| ₹73 L | ₹53 L |
| ₹2 Cr | ₹2 Cr |
| ₹2 Cr | ₹3 Cr |
| ₹6 L | ₹20 L |
| ₹3 Cr | ₹2 Cr |
| ₹7 Cr | ₹7 Cr |
| ₹6 Cr | ₹6 Cr |
| ₹1 L | ₹0 |
| ₹11 Cr | ₹11 Cr |
| ₹40 | ₹39 |
| ₹40 | ₹39 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 |
|---|---|
| ₹60 L | ₹55 L |
| ₹42 L | ₹30 L |
| -₹2 Cr | -₹2 Cr |
| -₹58 L | -₹72 L |
| -₹79 L | -₹88 L |
| -₹68 L | -₹73 L |
| ₹51 L | ₹4 Cr |
| -₹96 L | ₹2 Cr |
| ₹3 Cr | ₹70 L |
| ₹2 Cr | ₹3 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Clinitech Laboratory Share Price
30.00+0.00 (+0.00%)
-28.57% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 5 out of 9 oscillators
RSI
30.86Sell
STOCH %K
0.00Buy
MACD Level(12,26)
-2.40Sell
Ultimate Oscillator
20.02Sell
Aroon Oscillator
-74.00Sell
BOP
0.00Neutral
CCI
-133.00Buy
Williams %R
-100.00Buy
Momentum
-11.50Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 9 out of 9 moving averages
EMA 9
32.96Sell
SMA 9
33.19Sell
EMA 21
35.70Sell
SMA 21
37.43Sell
EMA 50
37.85Sell
SMA 50
38.06Sell
EMA 200
49.72Sell
SMA 200
45.52Sell
WMA 20
34.94Sell
Pivot
Pivot
Classic
Resistance 5
30.00
Resistance 4
30.00
Resistance 3
30.00
Resistance 2
30.00
Resistance 1
30.00
Pivot
30.00
Support 1
30.00
Support 2
30.00
Support 3
30.00
Support 4
30.00
Support 5
30.00
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Clinitech Laboratory Share Price
30.00+0.00 (+0.00%)
-28.57% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Mar 2026 | Sep 2025 | Mar 2025 | Sep 2024 |
|---|---|---|---|---|
| 64.62% | 64.20% | 62.42% | 61.58% | 61.58% |
| 0.32% | 0.32% | 0.32% | 0.32% | 0.32% |
| 0.63% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 34.43% | 35.48% | 37.26% | 38.10% | 38.10% |
Bulk & block deals
Name
Vorton Opportunities Fund
Binaben Bipinkumar Mehta
Siddharth Bipinbhai Mehta
Mukesh Keshubhai Thumar
Sanjay Harshadrai Mehta
Rahul R Mahajan
Sanjay Harshadrai Mehta
Binaben Bipinkumar Mehta
Kripananda Chidambaram
Bonanza Portfolio Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 16 Apr 2026 | Purchase | 6.41 L | ₹44.52 | 14.40 K | Bulk | 0.630915 | BSE |
| 23 Mar 2026 | Sell | 3.98 L | ₹33.20 | 12 K | Bulk | 0.525762 | BSE |
| 23 Mar 2026 | Purchase | 3.98 L | ₹33.20 | 12 K | Bulk | 0.525762 | BSE |
| 23 Mar 2026 | Sell | 5.54 L | ₹32.95 | 16.80 K | Bulk | 0.736067 | BSE |
| 17 Mar 2026 | Sell | 6 L | ₹33.34 | 18 K | Bulk | 0.788644 | BSE |
| 29 Jan 2026 | Sell | 3.54 L | ₹29.54 | 12 K | Bulk | 0.525762 | BSE |
| 29 Jan 2026 | Purchase | 5.04 L | ₹32.32 | 15.60 K | Bulk | 0.683491 | BSE |
| 17 Nov 2025 | Purchase | 5.30 L | ₹40.15 | 13.20 K | Bulk | 0.578339 | BSE |
| 19 Aug 2025 | Sell | 8.26 L | ₹52.97 | 15.60 K | Bulk | 0.683491 | BSE |
| 19 Aug 2025 | Sell | 1.91 L | ₹52.97 | 3.60 K | Bulk | 0.157729 | BSE |
Insider trading & SAST
Client name
Jagdish Nayak & Pacs
Jagdish Umakant Nayak
Siddhesh Anant Nayak & Pacs
Jagdish Umakant Nayak & Pacs
Jagdish Umakant Nayak
Jagdish Umakant Nayak & Pacs
Jagdish Umakant Nayak
Siddhesh Nayak & Pacs
Jagdish Umakant Nayak & Pacs
Mr. Jagdish Umakant Nayak
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 Apr 2026 | Promoter | Acquisition | 0.42 | 64.62 | 0 | — | 9.60 K | 30 Mar 2026 | Market | 14,75,000 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.37 | 30.92 | 0 | — | 8.40 K | 11 Mar 2026 | Market | 7,05,700 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.11 | 64.1 | 0 | — | 2.40 K | 24 Mar 2026 | Market | 14,63,000 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.05 | 64.15 | 0 | — | 1.20 K | 25 Mar 2026 | Market | 14,64,200 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.26 | 31.18 | 0 | — | 6 K | 12 Mar 2026 - 13 Mar 2026 | Market | 7,11,700 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.21 | 63.78 | 0 | — | 4.80 K | 17 Mar 2026 - 18 Mar 2026 | Market | 14,55,800 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.16 | 30.55 | 0 | — | 3.60 K | 10 Mar 2026 | Market | 6,97,300 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.05 | 64.2 | 0 | — | 1.20 K | 27 Mar 2026 | Market | 14,65,400 | SAST | 29(2) | — |
| 10 Apr 2026 | Promoter | Acquisition | 0.21 | 63.99 | 0 | — | 4.80 K | 19 Mar 2026 - 20 Mar 2026 | Market | 14,60,600 | SAST | 29(2) | — |
| 30 Mar 2026 | Promoter & Director | Acquisition | 0.42061 | 32.08 | 3.36 L | ₹35 | 9.60 K | 30 Mar 2026 | Market Purchase | 7,32,100 | Insider Trading | — | Equity Shares |
Clinitech Laboratory Share Price
30.00+0.00 (+0.00%)
-28.57% past 1 Year
Clinitech Laboratory is one of the most trusted diagnostic centers & pathology labs. The company is a provider of diagnostic and healthcare tests and services through chain of several diagnostic
Corporate Actions
Date
Type
Details
Company details
Clinitech Laboratory Share Price
30.00+0.00 (+0.00%)
-28.57% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
No presentations found
Clinitech Laboratory Share Price
30.00+0.00 (+0.00%)
-28.57% past 1 Year
News
Clinitech Laboratory informs about disclosure
Equity
CTLLAB
Clinitech Laboratory signs MoU with MD Plus Multispeciality Clinic
Equity
CTLLAB
Clinitech Laboratory informs about disclosure
Equity
CTLLAB
Clinitech Laboratory enters into MoU with M/s. MDM Dawudi Hospital
Equity
CTLLAB
Clinitech Laboratory informs about updates
Equity
CTLLAB
Clinitech Laboratory enters into Service Agreement with QB
Equity
CTLLAB
Clinitech Laboratory informs about disclosure
Equity
CTLLAB
Clinitech Laboratory informs about RTA certificate
Equity
CTLLAB
Clinitech Laboratory informs about board meeting
Equity
CTLLAB
Clinitech Laboratory opens new collection centre in Maharashtra
Equity
CTLLAB
Clinitech Laboratory informs about new collection centre
Equity
CTLLAB